Filed: 11/14/2024ACC: 0001974915-24-000011
📋 What this filing means
VESTAL POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 69 equity positions with a total reported market value of $1.32B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
69
Positions
$1.32B
Total AUM (reported)
80.24M
Total Shares
Allocation by class
COM$705.14M53.5%
COM NEW$118.66M9.0%
COM PAR $.01$116.80M8.9%
SHS USD$100.27M7.6%
SHS$66.20M5.0%
SPONSORED ADR$58.24M4.4%
SPONSORED ADS$58.09M4.4%
Portfolio Concentration
Top 3$296.27M22.5%
4–10$345.57M26.2%
11–25$410.14M31.1%
Rest$266.64M20.2%
Top 3 weight
22.5%
Top 10 weight
48.7%
Voting Authority Distribution
Total shares with voting rights: 80.24M
Sole
Full voting authority
80.24M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole69
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings69
Rows:
Insmed Inc
SOLEShares1.60M
TypeSH
Market value$116.80M
8.86%
Sole
1.60M
Shared
0.00
None
0.00
Jazz Pharmaceuticals PLC
SOLEShares900K
TypeSH
Market value$100.27M
7.60%
Sole
900K
Shared
0.00
None
0.00
Cytokinetics Inc
SOLEShares1.50M
TypeSH
Market value$79.20M
6.01%
Sole
1.50M
Shared
0.00
None
0.00
Inari Medical Inc
SOLEShares1.55M
TypeSH
Market value$63.92M
4.85%
Sole
1.55M
Shared
0.00
None
0.00
Arcellx Inc
SOLEShares675K
TypeSH
Market value$56.37M
4.27%
Sole
675K
Shared
0.00
None
0.00
Structure Therapeutics Inc
SOLEShares1.15M
TypeSH
Market value$50.47M
3.83%
Sole
1.15M
Shared
0.00
None
0.00
KalVista Pharmaceuticals Inc
SOLEShares4M
TypeSH
Market value$46.32M
3.51%
Sole
4M
Shared
0.00
None
0.00
Astria Therapeutics Inc
SOLEShares4M
TypeSH
Market value$44.04M
3.34%
Sole
4M
Shared
0.00
None
0.00
Immatics NV
SOLEShares3.75M
TypeSH
Market value$42.79M
3.24%
Sole
3.75M
Shared
0.00
None
0.00
Ultragenyx Pharmaceutical Inc
SOLEShares750K
TypeSH
Market value$41.66M
3.16%
Sole
750K
Shared
0.00
None
0.00
Ascendis Pharma A/S
SOLEShares250K
TypeSH
Market value$37.33M
2.83%
Sole
250K
Shared
0.00
None
0.00
Soleno Therapeutics Inc
SOLEShares720K
TypeSH
Market value$36.35M
2.76%
Sole
720K
Shared
0.00
None
0.00
Day One Biopharmaceuticals Inc
SOLEShares2.50M
TypeSH
Market value$34.83M
2.64%
Sole
2.50M
Shared
0.00
None
0.00
Savara Inc
SOLEShares8.09M
TypeSH
Market value$34.30M
2.60%
Sole
8.09M
Shared
0.00
None
0.00
Agios Pharmaceuticals Inc
SOLEShares760K
TypeSH
Market value$33.77M
2.56%
Sole
760K
Shared
0.00
None
0.00
Xenon Pharmaceuticals Inc
SOLEShares825K
TypeSH
Market value$32.48M
2.46%
Sole
825K
Shared
0.00
None
0.00
BioMarin Pharmaceutical Inc
SOLEShares400K
TypeSH
Market value$28.12M
2.13%
Sole
400K
Shared
0.00
None
0.00
Avadel Pharmaceuticals PLC
SOLEShares2M
TypeSH
Market value$26.23M
1.99%
Sole
2M
Shared
0.00
None
0.00
Biohaven Ltd
SOLEShares500K
TypeSH
Market value$24.98M
1.89%
Sole
500K
Shared
0.00
None
0.00
uniQure NV
SOLEShares4.75M
TypeSH
Market value$23.42M
1.78%
Sole
4.75M
Shared
0.00
None
0.00
Janux Therapeutics Inc
SOLEShares485K
TypeSH
Market value$22.03M
1.67%
Sole
485K
Shared
0.00
None
0.00
Black Diamond Therapeutics Inc
SOLEShares5.03M
TypeSH
Market value$21.87M
1.66%
Sole
5.03M
Shared
0.00
None
0.00
Solid Biosciences Inc
SOLEShares2.80M
TypeSH
Market value$19.52M
1.48%
Sole
2.80M
Shared
0.00
None
0.00
Edwards Lifesciences Corp
SOLEShares275K
TypeSH
Market value$18.15M
1.38%
Sole
275K
Shared
0.00
None
0.00
Gilead Sciences Inc
SOLEShares200K
TypeSH
Market value$16.77M
1.27%
Sole
200K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Insmed IncSOLE | COM PAR $.01 | 1.60M | SH | $116.80M 8.86% | 1.60M | 0.00 | 0.00 |
Jazz Pharmaceuticals PLCSOLE | SHS USD | 900K | SH | $100.27M 7.60% | 900K | 0.00 | 0.00 |
Cytokinetics IncSOLE | COM NEW | 1.50M | SH | $79.20M 6.01% | 1.50M | 0.00 | 0.00 |
Inari Medical IncSOLE | COM | 1.55M | SH | $63.92M 4.85% | 1.55M | 0.00 | 0.00 |
Arcellx IncSOLE | COMMON STOCK | 675K | SH | $56.37M 4.27% | 675K | 0.00 | 0.00 |
Structure Therapeutics IncSOLE | SPONSORED ADS | 1.15M | SH | $50.47M 3.83% | 1.15M | 0.00 | 0.00 |
KalVista Pharmaceuticals IncSOLE | COM | 4M | SH | $46.32M 3.51% | 4M | 0.00 | 0.00 |
Astria Therapeutics IncSOLE | COM | 4M | SH | $44.04M 3.34% | 4M | 0.00 | 0.00 |
Immatics NVSOLE | SHS | 3.75M | SH | $42.79M 3.24% | 3.75M | 0.00 | 0.00 |
Ultragenyx Pharmaceutical IncSOLE | COM | 750K | SH | $41.66M 3.16% | 750K | 0.00 | 0.00 |
Ascendis Pharma A/SSOLE | SPONSORED ADR | 250K | SH | $37.33M 2.83% | 250K | 0.00 | 0.00 |
Soleno Therapeutics IncSOLE | COM | 720K | SH | $36.35M 2.76% | 720K | 0.00 | 0.00 |
Day One Biopharmaceuticals IncSOLE | COM | 2.50M | SH | $34.83M 2.64% | 2.50M | 0.00 | 0.00 |
Savara IncSOLE | COM | 8.09M | SH | $34.30M 2.60% | 8.09M | 0.00 | 0.00 |
Agios Pharmaceuticals IncSOLE | COM | 760K | SH | $33.77M 2.56% | 760K | 0.00 | 0.00 |
Xenon Pharmaceuticals IncSOLE | COM | 825K | SH | $32.48M 2.46% | 825K | 0.00 | 0.00 |
BioMarin Pharmaceutical IncSOLE | COM | 400K | SH | $28.12M 2.13% | 400K | 0.00 | 0.00 |
Avadel Pharmaceuticals PLCSOLE | COM SHS | 2M | SH | $26.23M 1.99% | 2M | 0.00 | 0.00 |
Biohaven LtdSOLE | COM | 500K | SH | $24.98M 1.89% | 500K | 0.00 | 0.00 |
uniQure NVSOLE | SHS | 4.75M | SH | $23.42M 1.78% | 4.75M | 0.00 | 0.00 |
Janux Therapeutics IncSOLE | COM | 485K | SH | $22.03M 1.67% | 485K | 0.00 | 0.00 |
Black Diamond Therapeutics IncSOLE | COM | 5.03M | SH | $21.87M 1.66% | 5.03M | 0.00 | 0.00 |
Solid Biosciences IncSOLE | COM NEW | 2.80M | SH | $19.52M 1.48% | 2.80M | 0.00 | 0.00 |
Edwards Lifesciences CorpSOLE | COM | 275K | SH | $18.15M 1.38% | 275K | 0.00 | 0.00 |
Gilead Sciences IncSOLE | COM | 200K | SH | $16.77M 1.27% | 200K | 0.00 | 0.00 |
Page 1 of 3